Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study

Autor: Ferrandina, G *, Ludovisi, M, De Vincenzo, R, Salutari, V, Lorusso, D, Colangelo, M, Prantera, T, Valerio, M.R., Scambia, G
Zdroj: In Annals of Oncology August 2007 18(8):1348-1353
Databáze: ScienceDirect